Pharmafile Logo
Pharmafocus logo
Advanced Search

ABPI

Showing 15 posts of 321 posts found.

Doubts about funding for ‘Innovation Pass’

August 10, 2009
Research and Development, Sales and Marketing ABPI, NHS, NICE

The new fast-tracking system announced to help accelerate uptake of innovative new treatments in the UK, could be held back …

News

NICE bypassed in radical innovation boost

July 16, 2009
Research and Development, Sales and Marketing ABPI, Blueprint, NICE, hta

Ministers have sidestepped NICE in their bid to boost innovation in life sciences, and said certain medicines can made available …

News

Blueprint to fast track innovative drugs and devices

July 14, 2009
Research and Development, Sales and Marketing ABPI, Blueprint, NHS

A new 'Blueprint' to put innovation at the heart of the NHS and help support the UK life sciences sector …

News

Roche’s ABPI exit – a deliberate snub?

July 3, 2009
Research and Development, Sales and Marketing ABPI, Roche

 By Nicola O’BrienRoche is yet to explain its controversial exit from the ABPI, but the company seems determined to make …

News

Roche quits ABPI

June 30, 2009
Research and Development, Sales and Marketing ABPI, Roche, UK

Roche is to give up its ABPI membership in a surprise move that could undermine the UK’s system of industry …

News

Ambassadors’ sought for ambitious engagement plan

June 5, 2009
Sales and Marketing ABPI

People from across the industry are being asked to volunteer as 'ambassadors' for the pharma sector to conduct a large-scale …

News

ABPI looks to breathe new life into industry relations

May 20, 2009
Medical Communications, Sales and Marketing ABPI, doctors, industry relations, medical education, vita

The ABPI has unveiled a new proactive agenda which it hopes will help improve the industry’s reputation and relationships with …

Feature

Pharma welcomes UK taxation pledge

April 23, 2009
ABPI

The UK government budget delivered in the gloom of the recession has provided good news for the industry, according to …

News

Pharma-NHS joint working

April 22, 2009
Research and Development, Sales and Marketing ABPI, doctors, industry relations

An underlying principle for joint working between the NHS and the pharmaceutical industry is that it brings benefits to patients. …

Feature

Frustration over pharma’s digital marketing impasse

April 8, 2009
Sales and Marketing ABPI, digi

News

Roche and Bayer Schering ‘named and shamed’ for Code breaches

March 3, 2009
Sales and Marketing ABPI, Code of Practice

Roche and Bayer Schering Pharma have been publically reprimanded for bringing discredit upon the UK pharma industry.Bayer fell foul of …

News

Pharma needs fresh ideas from outside industry, says Barker

February 17, 2009
Research and Development, Sales and Marketing ABPI, strategy

Pharma must re-invent itself and inject new ideas into its business model by hiring talented people from outside the sector, …

News

Health secretary to chair influential pharma group

February 11, 2009
Sales and Marketing ABPI, reform

Health Secretary Alan Johnson has been appointed the chair of the Ministerial Industry Strategy Group (MISG) and business secretary Lord …

News

UK pharma to consider ban on doctor gifts

February 5, 2009
Medical Communications ABPI, Code of Practice, ethics

All gifts from pharma companies to doctors and to medical students – should be banned, according to a new report …

News

UK pharma to lose

January 8, 2009
Sales and Marketing ABPI, NHS, par

The UK pharmaceutical industry stands to lose £225 million in annual profits under its new pricing agreement with the government. …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026